Child emotional and behavioural adjustment; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Parenting skills; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Parental depression or anxiety; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Parenting stress; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Parent mindfulness; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Measures of self‐compassion · parents of children between the ages of 0 and 18 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · parents of children between the ages of 0 and 18 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Parenting skills; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Parental depression or anxiety; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Parenting stress; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Parent mindfulness; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Measures of self‐compassion · parents of children between the ages of 0 and 18 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Child emotional and behavioural adjustment; postintervention · parents of children between the ages of 0 and 18 years
1 finding from 1 review
Adverse effects · parents of children between the ages of 0 and 18 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events at longest · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical relapse · patients with Crohn's disease (mixed disease activity population with clinical response at baseline)
Infliximab probably leads to lower clinical relapse (at 30‐32 weeks, CDAI > 150) compared with placebo (moderate certainty).
1 finding from 1 review
Loss of clinical response · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found